Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost ...

Their continuous, bubble-free manufacturing platform with a novel 3D printed bioreactor enhances yields, reduces costs, and minimizes footprint and energy consumption. Stämm's approach enables a ...

Pilot runs in Europe and South America show breakthrough efficiency in monoclonal antibody production with unprecedented cost savings and scalability using Stämm's bubble-free continuous laminar ...